July 26, 2016 7:16 AM ET

Life Sciences Tools and Services

Company Overview of CHDI Foundation, Inc.

Company Overview

CHDI Foundation, Inc., a not-for-profit research organization, engages in discovering and developing drugs that delay or slow the progression of Huntington's disease (HD). It supports and collaborates with a network of scientists in academic and industrial laboratories in the United States and internationally to discover drugs that slow the progression or delay the onset of HD. The company also provides financial support for research, as well as organizes workshops that bring scientists together to discuss ongoing programs, explore emerging questions, evaluate new technologies, and establish new partnerships and projects. In addition, it offers research tools and information to HD researcher...

6080 Center Drive

Suite 100

Los Angeles, CA 90045

United States

Founded in 2003





Key Executives for CHDI Foundation, Inc.

Age: 59
Chief Operating Officer
Chief Administrative Officer
Chief Legal Officer
Compensation as of Fiscal Year 2016.

CHDI Foundation, Inc. Key Developments

Evotec AG and CHDI Foundation, Inc. Extends Collaboration to Find New Treatments for Huntington's Disease

Evotec AG has announced that CHDI Foundation, Inc. has extended and restated its collaboration with Evotec through 2017 to find new treatments for Huntington's disease. The collaboration-which aims to find new treatments for Huntington's disease, means that CHDI will fund up to 52 full-time scientists at Evotec over the next three years. The collaboration initially began in 2006 and has expanded considerably over this period to fully leverage Evotec's integrated neuroscience platform. The restated extension of this collaboration is a further validation of Evotec's broad drug discovery expertise in the field of neuroscience and includes an expansion to utilise Evotec's high-throughput screening and proteomics platforms. Evotec provides a full range of research activities and expertise in the neuroscience area to CHDI, including integrated biology and chemistry supported by compound and library management, target validation, stem cell research, high-content screening, computational chemistry, in vitro pharmacokinetics and protein production.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHDI Foundation, Inc., please visit www.chdi-inc.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.